Houston AI company OmniScience hit a major milestone with a new partnership, and its CEO said it will be the first of many models in clinical trials. A Houston company developing artificial ...
Dec. 04, 2024 (GLOBE NEWSWIRE) -- OmniScience and INmune Bio (NASDAQ: INMB) today announced a pioneering partnership to revolutionize operations for INmune Bio’s global Phase 2 Alzheimer’s ...
(RTTNews) - OmniScience Inc. and INmune Bio Inc. (INMB), a clinical-stage biotechnology company, announced a partnership on Tuesday to enhance the operations of INmune Bio's global Phase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback